RM, v. S., SL, A., K, S., FJ, H., EP, H., API, H., . . . WJ, v. D. (2023). Is routine admission to a critical care setting following hyperthermic intraperitoneal chemotherapy for ovarian cancer necessary? European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 49(12), 107084. https://doi.org/10.1016/j.ejso.2023.107084
Chicago Style (17th ed.) CitationRM, van Stein, et al. "Is Routine Admission to a Critical Care Setting Following Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer Necessary?" European Journal of Surgical Oncology : The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 49, no. 12 (2023): 107084. https://doi.org/10.1016/j.ejso.2023.107084.
MLA (9th ed.) CitationRM, van Stein, et al. "Is Routine Admission to a Critical Care Setting Following Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer Necessary?" European Journal of Surgical Oncology : The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, vol. 49, no. 12, 2023, p. 107084, https://doi.org/10.1016/j.ejso.2023.107084.